For the first time, NYSCF scientists generated induced pluripotent stem (iPS) cells lines from skin samples of patients with primary progressive multiple sclerosis and further, they...
NYSCF – Robertson Neuroscience Investigator Dr. Zachary Knight and his team from the Universtiy of California, San Francisco conducted experiments that overthrow the scientific consensus on...
The NYSCF Research Institute is partnering with the Stanley Center at the Broad Institute of MIT and Harvard to develop a stem cell resource to study...
NYSCF – Robertson Neuroscience Investigator Dr. Winrich Freiwald, The Rockefeller University, published his latest work on macaque facila processing in Current Biology. The researchers identified a...
NYSCF – Robertson Neuroscience Investigator Dr. Ed Boyden, MIT Media Lab, described in Science the newest technology developed in his lab for imaging biological samples. The technology,...
NYSCF – Robertson Stem Cell Investigator Dr. Alex Meissner, Harvard University, published the lastest research out of his lab investigating the regulation of neural cell differentiation...
NYSCF and the Charcot-Marie-Tooth Association (CMTA), a patient-led disease foundation with a mission to advance research on genetic neuropathies leading to the development of new therapies,...
NYSCF announced that Dr. Marius Wernig, of Stanford University, is the recipient of the NYSCF – Robertson Stem Cell Prize. Dr. Wernig and his team discovered...
NYSCF – Robertson Stem Cell Investigator Dr. Kristen Brennand of the Icahn School of Medicine at Mount Sinai led a team of scientists that discovered that...
NYSCF – Robertson Stem Cell Investigator Dr. Gabsang Lee, of John’s Hopkins University School of Medicine, was senior author on a Cell Stem Cell paper describing...
NYSCF – Robertson Stem Cell Investigator Dr. Paola Arlotta, of Harvard University, published her latest work on gene co-regulation in Nature Neuroscience. The regulatory logic, or...
To address the unmet needs of patients, NYSCF researchers have been at the forefront of rare disease research. Scientists at the NYSCF Research Institute, our Fellows,...
Paola Arlotta, a NYSCF – Robertson Stem Cell Investigator, has reported in Nature Cell Biology the possibility to reprogram one type of neuron into another in...
